• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Plandai Biotechnologies, Inc. Announces Termination of Asset Acquisition Agreement with EV Hotel, Updates on Status of Independent Audit

Share:

January 9, 2023

SAN DIEGO, CA / ACCESSWIRE / January 4, 2023 / (OTC:PLPL) Plandai Biotechnology, Inc. (“Plandai” or the “Company”) announces the termination of its previously announced asset acquisition agreement with EV Hotel Corp., a Georgia corporation. The termination was agreed to by both parties, and the Company incurred no penalties, costs, or liabilities in connection with the termination.

The Company completed its two-year independent audit of its financial statements and will use them as a basis for future disclosures and its continuing merger and acquisition efforts.

About:

Plandai Biotechnology, Inc., a Nevada corporation, is a publicly quoted shell company seeking to create value for its shareholders by merging with another entity with experienced management and opportunities for growth.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Source: Bio Space

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Laminar, Inc. Acquired by Johnson & Johnson Medtech for $400 Million Upfront with Additional Clinical and Regulatory Milestone Payments in 2024 and Beyond.Laminar, Inc. Acquired by Johnson & Johnson Medtech for $400 Million Upfront with Additional Clinical and Regulatory Milestone Payments in 2024 and Beyond.
  • Innovaccer, Surescripts Integrate to Leverage Medication Data for PatientsInnovaccer, Surescripts Integrate to Leverage Medication Data for Patients
  • FDA Clears Eko’s AFib, Heart Murmur Detection Algorithms for AI-Powered StethoscopeFDA Clears Eko’s AFib, Heart Murmur Detection Algorithms for AI-Powered Stethoscope
  • Gilead Sciences Completes Acquisition of Immunomedics, Inc.Gilead Sciences Completes Acquisition of Immunomedics, Inc.
  • Market Insights of Aseptic Packaging for the Pharmaceutical Market By Top Leading Players, Key Strategies & Market Dynamics ForcesMarket Insights of Aseptic Packaging for the Pharmaceutical Market By Top Leading Players, Key Strategies & Market Dynamics Forces
  • How Healthcare can Weaponize Data to Fight Worldwide DiseaseHow Healthcare can Weaponize Data to Fight Worldwide Disease
  • Dubai Health Authority Works on Enhancing Smart Health Technology ServicesDubai Health Authority Works on Enhancing Smart Health Technology Services
  • Xsolis Announces Acquisition of MedarchonXsolis Announces Acquisition of Medarchon

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications